• 2021
  Nardella F, Halby L, Dobrescu I, Viluma J, Bon C, Claes A, Cadet-Daniel V, Tafit A, Roesch C, Hammam E, Erdmann D, Mairet-Khedim M, Peronet R, Mecheri S, Witkowski B, Scherf A, Arimondo PB, , Procainamide-SAHA Fused Inhibitors of hHDAC6 Tackle Multidrug-Resistant Malaria Parasites., J Med Chem 2021 Jul; 64(14): 10403-10417.
• 2017
  Demarta-Gatsi C, Peronet R, Smith L, Thiberge S, Ménard R, Mécheri S, Immunological memory to blood-stage malaria infection is controlled by the histamine releasing factor (HRF) of the parasite, Sci Rep 2017 08;7(1):9129.
• 2017
  Roussilhon C, Bang G, Bastaert F, Solhonne B, Garcia-Verdugo I, Peronet R, Druilhe P, Sakuntabhai A, Mecheri S, Sallenave JM, The antimicrobial molecule trappin-2/elafin has anti-parasitic properties and is protective in vivo in a murine model of cerebral malaria, Sci Rep 2017 Feb;7:42243.
• 2016
  Chen PB, Ding S, Zanghì G, Soulard V, DiMaggio PA, Fuchter MJ, Mecheri S, Mazier D, Scherf A, Malmquist NA, Plasmodium falciparum PfSET7: enzymatic characterization and cellular localization of a novel protein methyltransferase in sporozoite, liver and erythrocytic stage parasites, Sci Rep 2016 Feb;6:21802.
• 2015
  Herrant M, Loucoubar C, Boufkhed S, Bassène H, Sarr FD, Baril L, Mercereau-Puijalon O, Mécheri S, Sakuntabhai A, Paul R, Risk factors associated with asthma, atopic dermatitis and rhinoconjunctivitis in a rural Senegalese cohort, Allergy Asthma Clin Immunol 2015;11(1):24.
• 2015
  Briquet S, Lawson-Hogban N, Boisson B, Soares MP, Péronet R, Smith L, Ménard R, Huerre M, Mécheri S, Vaquero C, Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity, Infect. Immun. 2015 Jul;83(7):2771-84.
• 2014
  Mathieu C, Demarta-Gatsi C, Porcherie A, Brega S, Thiberge S, Ronce K, Smith L, Peronet R, Amino R, Ménard R, Mécheri S, Plasmodium berghei histamine-releasing factor favours liver-stage development via inhibition of IL-6 production and associates with a severe outcome of disease, Cell. Microbiol. 2015 Apr;17(4):542-58.
• 2013
  Kanjarawi R, Dy M, Bardel E, Sparwasser T, Dubois B, Mecheri S, Kaiserlian D, Regulatory CD4+Foxp3+ T cells control the severity of anaphylaxis, PLoS ONE 2013;8(7):e69183.
• 2012
  Malmquist NA, Moss TA, Mecheri S, Scherf A, Fuchter MJ, Small-molecule histone methyltransferase inhibitors display rapid antimalarial activity against all blood stage forms in Plasmodium falciparum, Proc. Natl. Acad. Sci. U.S.A. 2012 Oct;109(41):16708-13.
• 2012
  Li T, Bourgeois JP, Celli S, Glacial F, Le Sourd AM, Mecheri S, Weksler B, Romero I, Couraud PO, Rougeon F, Lafaye P, Cell-penetrating anti-GFAP VHH and corresponding fluorescent fusion protein VHH-GFP spontaneously cross the blood-brain barrier and specifically recognize astrocytes: application to brain imaging, FASEB J. 2012 Oct;26(10):3969-79.
• 2012
  Lawaly R, Konate L, Marrama L, Dia I, Diallo D, Diène Sarr F, Schneider BS, Casademont I, Diallo M, Brey PT, Sakuntabhai A, Mecheri S, Paul R, , Impact of mosquito bites on asexual parasite density and gametocyte prevalence in asymptomatic chronic Plasmodium falciparum infections and correlation with IgE and IgG titers., Infect. Immun. 2012 Jun; 80(6): 2240-6.
• 2012
  Terme M, Ullrich E, Aymeric L, Meinhardt K, Coudert JD, Desbois M, Ghiringhelli F, Viaud S, Ryffel B, Yagita H, Chen L, Mécheri S, Kaplanski G, Prévost-Blondel A, Kato M, Schultze JL, Tartour E, Kroemer G, Degli-Esposti M, Chaput N, Zitvogel L, Cancer-induced immunosuppression: IL-18-elicited immunoablative NK cells, Cancer Res. 2012 Jun;72(11):2757-67.
• 2011
  Blank U, Mécheri S, Duality and complexity of allergic type inflammatory mechanisms in determining the outcome of malaria disease, Front Immunol 2011;2:78.
• 2011
  Porcherie A, Mathieu C, Peronet R, Schneider E, Claver J, Commere PH, Kiefer-Biasizzo H, Karasuyama H, Milon G, Dy M, Kinet JP, Louis J, Blank U, Mécheri S, Critical role of the neutrophil-associated high-affinity receptor for IgE in the pathogenesis of experimental cerebral malaria, J. Exp. Med. 2011 Oct;208(11):2225-36.
• 2011
  Schneider E, Machavoine F, Bricard-Rignault R, Levasseur M, Petit-Bertron AF, Gautron S, Ribeil JA, Launay JM, Mecheri S, Côté F, Dy M, Downregulation of basophil-derived IL-4 and in vivo T(H)2 IgE responses by serotonin and other organic cation transporter 3 ligands, J. Allergy Clin. Immunol. 2011 Oct;128(4):864-871.e2.
• 2011
  Schneider BS, Mathieu C, Peronet R, Mécheri S, Anopheles stephensi saliva enhances progression of cerebral malaria in a murine model, Vector Borne Zoonotic Dis. 2011 Apr;11(4):423-32.
• 2011
  Mecheri S, Contribution of allergic inflammatory response to the pathogenesis of malaria disease, Biochim. Biophys. Acta 2012 Jan;1822(1):49-56.
• 2010
  Ortonne N, Ram-Wolff C, Giustiniani J, Marie-Cardine A, Bagot M, Mecheri S, Bensussan A, Human and mouse mast cells express and secrete the GPI-anchored isoform of CD160, J. Invest. Dermatol. 2011 Apr;131(4):916-24.
• 2010
  Fernandez P, Petres S, Mécheri S, Gysin J, Scherf A, Strain-transcendent immune response to recombinant Var2CSA DBL5-ε domain block P. falciparum adhesion to placenta-derived BeWo cells under flow conditions, PLoS ONE 2010;5(9):e12558.
• 2009
  Beghdadi W, Porcherie A, Schneider BS, Morisset S, Dubayle D, Peronet R, Dy M, Louis J, Arrang JM, Mécheri S, Histamine H(3) receptor-mediated signaling protects mice from cerebral malaria, PLoS ONE 2009;4(6):e6004.
• 2009
  Beghdadi W, Porcherie A, Schneider BS, Dubayle D, Peronet R, Huerre M, Watanabe T, Ohtsu H, Louis J, Mécheri S, [Role of histamine and histamine receptors in the pathogenesis of malaria], Med Sci (Paris) 2009 Apr;25(4):377-81.
• 2008
  Beghdadi W, Porcherie A, Schneider BS, Dubayle D, Peronet R, Huerre M, Watanabe T, Ohtsu H, Louis J, Mécheri S, Inhibition of histamine-mediated signaling confers significant protection against severe malaria in mouse models of disease, J. Exp. Med. 2008 Feb;205(2):395-408.
• 2007
  Duarte J, Deshpande P, Guiyedi V, Mécheri S, Fesel C, Cazenave PA, Mishra GC, Kombila M, Pied S, Total and functional parasite specific IgE responses in Plasmodium falciparum-infected patients exhibiting different clinical status, Malar. J. 2007;6:1.
• 2006
  Depinay N, Hacini F, Beghdadi W, Peronet R, Mécheri S, Mast cell-dependent down-regulation of antigen-specific immune responses by mosquito bites, J. Immunol. 2006 Apr;176(7):4141-6.
• 2005
  Bouziane H, Latgé JP, Fitting C, Mecheri S, Lelong M, David B, Comparison of the allergenic potency of spores and mycelium of Cladosporium, Allergol Immunopathol (Madr) 2005 May-Jun;33(3):125-30.
• 2005
  Demeure CE, Brahimi K, Hacini F, Marchand F, Péronet R, Huerre M, St-Mezard P, Nicolas JF, Brey P, Delespesse G, Mécheri S, Anopheles mosquito bites activate cutaneous mast cells leading to a local inflammatory response and lymph node hyperplasia, J. Immunol. 2005 Apr;174(7):3932-40.
• 2004
  Borg C, Terme M, Taïeb J, Ménard C, Flament C, Robert C, Maruyama K, Wakasugi H, Angevin E, Thielemans K, Le Cesne A, Chung-Scott V, Lazar V, Tchou I, Crépineau F, Lemoine F, Bernard J, Fletcher JA, Turhan A, Blay JY, Spatz A, Emile JF, Heinrich MC, Mécheri S, Tursz T, Zitvogel L, Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects, J. Clin. Invest. 2004 Aug;114(3):379-88.
• 2003
  Marchand F, Mecheri S, Guilloux L, Iannascoli B, Weyer A, Blank U, Human serum IgE-mediated mast cell degranulation shows poor correlation to allergen-specific IgE content, Allergy 2003 Oct;58(10):1037-43.
• 2003
  Bérard F, Saint-Mezard P, Cousin F, Mecheri S, Nicolas JF, [Immunological and non immunological mechanisms in urticaria], Ann Dermatol Venereol 2003 May;130 Spec No 1:1S10-5.
• 2003
  Skokos D, Botros HG, Demeure C, Morin J, Peronet R, Birkenmeier G, Boudaly S, Mécheri S, Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo, J. Immunol. 2003 Mar;170(6):3037-45.
• 2002
  Skokos D, Goubran-Botros H, Roa M, Mécheri S, Immunoregulatory properties of mast cell-derived exosomes, Mol. Immunol. 2002 Sep;38(16-18):1359-62.
• 2001
  Villa I, Skokos D, Tkaczyk C, Peronet R, David B, Huerre M, Mécheri S, Capacity of mouse mast cells to prime T cells and to induce specific antibody responses in vivo, Immunology 2001 Feb;102(2):165-72.
• 2001
  Skokos D, Le Panse S, Villa I, Rousselle JC, Peronet R, David B, Namane A, Mécheri S, Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes, J. Immunol. 2001 Jan;166(2):868-76.
• 2001
  Skokos D, Le Panse S, Villa I, Rousselle JC, Peronet R, Namane A, David B, Mécheri S, Nonspecific B and T cell-stimulatory activity mediated by mast cells is associated with exosomes, Int. Arch. Allergy Immunol. 2001 Jan-Mar;124(1-3):133-6.
• 2000
  Tkaczyk C, Villa I, Peronet R, David B, Chouaib S, Mécheri S, In vitro and in vivo immunostimulatory potential of bone marrow-derived mast cells on B- and T-lymphocyte activation, J. Allergy Clin. Immunol. 2000 Jan;105(1 Pt 1):134-42.
• 1999
  Tkaczyk C, Villa I, Peronet R, David B, Mécheri S, FcepsilonRI-mediated antigen endocytosis turns interferon-gamma-treated mouse mast cells from inefficient into potent antigen-presenting cells, Immunology 1999 Jun;97(2):333-40.
• 1998
  Dimitriadou V, Mécheri S, Koutsilieris M, Fraser W, Al-Daccak R, Mourad W, Expression of functional major histocompatibility complex class II molecules on HMC-1 human mast cells, J. Leukoc. Biol. 1998 Dec;64(6):791-9.
• 1998
  Tkaczyk C, Viguier M, Boutin Y, Frandji P, David B, Hébert J, Mécheri S, Specific antigen targeting to surface IgE and IgG on mouse bone marrow-derived mast cells enhances efficiency of antigen presentation, Immunology 1998 Jul;94(3):318-24.
• 1998
  Frandji P, Mourad W, Tkaczyk C, Singer M, David B, Colle JH, Mécheri S, IL-4 mRNA transcription is induced in mouse bone marrow-derived mast cells through an MHC class II-dependent signaling pathway, Eur. J. Immunol. 1998 Mar;28(3):844-54.
• 1997
  Raposo G, Tenza D, Mecheri S, Peronet R, Bonnerot C, Desaymard C, Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation, Mol. Biol. Cell 1997 Dec;8(12):2631-45.
• 1997
  Bernatchez C, Al-Daccak R, Mayer PE, Mehindate K, Rink L, Mecheri S, Mourad W, Functional analysis of Mycoplasma arthritidis-derived mitogen interactions with class II molecules, Infect. Immun. 1997 Jun;65(6):2000-5.
• 1997
  Mécheri S, David B, Unravelling the mast cell dilemma: culprit or victim of its generosity?, Immunol. Today 1997 May;18(5):212-5.
• 1996
  Frandji P, Tkaczyk C, Oskeritzian C, David B, Desaymard C, Mécheri S, Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes, Eur. J. Immunol. 1996 Oct;26(10):2517-28.
• 1996
  Tkaczyk C, Frandji P, Botros HG, Poncet P, Lapeyre J, Peronet R, David B, Mécheri S, Mouse bone marrow-derived mast cells and mast cell lines constitutively produce B cell growth and differentiation activities, J. Immunol. 1996 Aug;157(4):1720-8.
• 1995
  Frandji P, Tkaczyk C, Oskéritzian C, Lapeyre J, Peronet R, David B, Guillet JG, Mécheri S, Presentation of soluble antigens by mast cells: upregulation by interleukin-4 and granulocyte/macrophage colony-stimulating factor and downregulation by interferon-gamma, Cell. Immunol. 1995 Jun;163(1):37-46.
• 1994
  Mehindate K, al-Daccak R, Rink L, Mecheri S, Hébert J, Mourad W, Modulation of Mycoplasma arthritidis-derived superantigen-induced cytokine gene expression by dexamethasone and interleukin-4, Infect. Immun. 1994 Nov;62(11):4716-21.
• 1994
  al-Daccak R, Mehindate K, Hébert J, Rink L, Mecheri S, Mourad W, Mycoplasma arthritidis-derived superantigen induces proinflammatory monokine gene expression in the THP-1 human monocytic cell line, Infect. Immun. 1994 Jun;62(6):2409-16.
• 1993
  Frandji P, Oskéritzian C, Cacaraci F, Lapeyre J, Peronet R, David B, Guillet JG, Mécheri S, Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma, J. Immunol. 1993 Dec;151(11):6318-28.
• 1993
  Mécheri S, Dannecker G, Dennig D, Poncet P, Hoffmann MK, Anti-histone autoantibodies react specifically with the B cell surface, Mol. Immunol. 1993 Apr;30(6):549-57.
• 1993
  Dannecker G, Schultz H, Mecheri S, Sappler G, Clarke K, Niethammer D, Hoffmann MK, Characterization of anergy to the superantigen Staphylococcus enterotoxin B, Immunodeficiency 1993;4(1-4):137-9.
• 1993
  Dannecker G, Mecheri S, Heuser M, Ihle J, Hoffmann MK, Niethammer D, Differential expression of T cell receptor variable beta genes on CD4+ and CD8+ T cells: influence by sex linked genes?, Immunobiology 1993 Jan;187(1-2):17-23.
• 1992
  Dannecker G, Mecheri S, Clarke K, Dudhane A, Wang ZQ, Hoffmann MK, A stimulatory Mls-1 superantigen is destroyed by ultraviolet light while other Mtv-7 antigens remain intact. Significance for Mls-1 unresponsiveness, J. Immunol. 1992 Dec;149(11):3463-7.
• 1992
  Hoffmann MK, Dannecker G, Mecheri S, Regulation of T cell function by Mtv-7 gene products, Semin. Immunol. 1992 Oct;4(5):337-51.
• 1992
  Dennig D, Mecheri S, Bourhis JH, Hoffman MK, Interleukin-2 may enhance or inhibit antibody production by B cells depending on intracellular cAMP concentrations, Immunology 1992 Oct;77(2):251-5.
• 1992
  Dannecker G, Mecheri S, Hoffmann MK, In vivo presentation of Mls-1 antigen by T and B lymphocytes, Immunobiology 1992 Jun;185(1):20-7.
• 1991
  Mecheri S, Dannecker G, Dennig D, Hoffmann MK, B cells control the aggregability of CD4 on T cells through continuous physical interactions, Immunology 1991 Dec;74(4):606-12.
• 1991
  Dannecker G, Mecheri S, Hoffmann MK, Induction of neonatal tolerance to the Mls-1a self-super-antigen. Time kinetics and MHC restriction, J. Immunol. 1991 Nov;147(9):2833-8.
• 1991
  Dannecker G, Mecheri S, Staiano-Coico L, Hoffmann MK, A characteristic Mls-1a response precedes Mls-1a anergy in vivo, J. Immunol. 1991 Apr;146(7):2083-7.
• 1991
  Dennig D, Mecheri S, Dannecker G, Kimura S, Hoffmann M, Does interleukin-1 save B cells from paralysis? Studies with pre-B cells and antigen-reactive B cells, Lymphokine Cytokine Res. 1991 Apr;10(1-2):27-34.
• 1990
  Mecheri S, Dannecker G, Dennig D, Hoffmann MK, Immunogenic peptides require an undisturbed phospholipid cell membrane environment and must be amphipathic to immobilize Ia on B cells, J. Immunol. 1990 Feb;144(4):1369-74.
• 1990
  Mecheri S, Edidin M, Dannecker G, Mittler RS, Hoffmann MK, Immunogenic Ia-binding peptides immobilize the Ia molecule and facilitate its aggregation on the B cell membrane. Control by the M1s-1 gene, J. Immunol. 1990 Feb;144(4):1361-8.
• 1989
  Bouziane H, Latgé JP, Mecheri S, Fitting C, Prévost MC, Release of allergens from Cladosporium conidia, Int. Arch. Allergy Appl. Immunol. 1989;88(3):261-6.
• 1988
  Mourad W, Mécheri S, Peltre G, David B, Hébert J, Study of the epitope structure of purified Dac G I and Lol p I, the major allergens of Dactylis glomerata and Lolium perenne pollens, using monoclonal antibodies, J. Immunol. 1988 Nov;141(10):3486-91.
• 1988
  Mecheri S, Mourad W, Lapeyre J, Jobin M, David B, Hébert J, Demonstration of idiotypes expressed on basophil-bound IgE antibodies by using anti-idiotype-induced histamine release in grass pollen-allergic patients, Immunology 1988 May;64(1):11-5.
• 1987
  Mécheri S, Peltre G, Lapeyre J, David B, Biological effect of transferrin on mast cell mediator release during the passive cutaneous anaphylaxis reaction: a possible inhibition mechanism involving iron, Ann. Inst. Pasteur Immunol. 1987 Mar-Apr;138(2):213-21.
• 1985
  Mécheri S, Peltre G, Weyer A, David B, Production of a monoclonal antibody against a major allergen of Dactylis glomerata pollen (Dg1), Ann. Inst. Pasteur Immunol. 1985 Mar-Apr;136C(2):195-209.
• 1985
  Mecheri S, Peltre G, David B, Purification and characterization of a major allergen from Dactylis glomerata pollen: the Ag Dg1, Int. Arch. Allergy Appl. Immunol. 1985;78(3):283-9.
• 1985
  Mecheri S, Peltre G, David B, Induction of a passive cutaneous anaphylaxis inhibitory factor in mice, Int. Arch. Allergy Appl. Immunol. 1985;78(3):290-9.
• 1984
  Cavaillon JM, Dandeu JP, Mécheri S, David B, Presence of IL 1 activity in the supernatant of human monocytes challenged with purified allergenic constituents, Int. Arch. Allergy Appl. Immunol. 1984;75(2):113-9.
• 1983
  Mecheri S, Peltre G, David B, Inhibition of the passive cutaneous anaphylaxis reaction to Dactylis glomerata pollen allergens by a purified component of this pollen, Immunol. Lett. 1983 May;6(5):257-63.
• 1983
  Dunier M, Singh SN, Mecheri S, Luffau G, Pery P, Paraf A, Relationship between cytidine 5’diphosphocholine epitope density on ovalbumin and IgE antibody responses compared to other isotypes, Ann. Rech. Vet. 1983;14(1):49-55.
• 1975
  Korelitz BI, Sommers SC, Responses to drug therapy in ulcerative colitis. Evaluation by rectal biopsy and histopathological changes, Am. J. Gastroenterol. 1975 Nov;64(5):365-70.